Federal regulations permit the applicant/employee to request the split specimen that was collected at the time of the original specimen be sent to another laboratory for testing. This request should be made to the MRO within 72 hours of the employee being notified of the positive test result.
Shiga toxin-producing E. coli(STEC), also called verotoxinogenic E. coli, usually do not cause disease inanimals but may cause watery diarrhoea, haemorrhagic colitis, and/orhaemolytic uraemic syndrome in humans. Zoonotic STEC include the O157:H7strains and, with increasing frequency, certain non-O157 strains.
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Vedanta Biosciences, an affiliate of PureTech Health (LSE: PRTC) developing a new category of therapies for immune-mediated and infectious diseases based on rationally defined consortium of human microbiome-derived bacteria, today announced the initiation of a Phase 1a/1b, first-in-human, clinical trial of VE303, the Companyâs lead, orally-administered microbiome therapeutic product candidate for recurrent Clostridium difficile infection (rCDI).